BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Editas Medicine

Editas Medicine logo

Founded
2013
Patents
70
Clinical Trials
2
Publications
50

Technologies

CRISPR Startups Gene Therapy Startups

Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Posts Mentioning This Company

A Race For Better Gene Editing Tech Is On

  
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least in research laboratories, where scientists efficiently adopted CRISPR technology to manipulate genes of interest. Still, applying it for humans is associated with greater risks and faces ethical issues. However, alongside …